These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20669601)

  • 21. 24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures.
    Carreño JE; Bobes J; Brewer C; Alvarez CE; San Narciso GI; Bascarán MT; Sánchez del Río J
    Addict Biol; 2002 Apr; 7(2):243-50. PubMed ID: 12006220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug injecting in patients in New Zealand Methadone Maintenance Treatment programs: an anonymous survey.
    Judson G; Bird R; O'Connor P; Bevin T; Loan R; Schroder M; McGrath R; Weatherall M; Moriarty H; Robinson G
    Drug Alcohol Rev; 2010 Jan; 29(1):41-6. PubMed ID: 20078681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naltrexone in addicted physicians and business executives.
    Washton AM; Gold MS; Pottash AC
    NIDA Res Monogr; 1984; 55():185-90. PubMed ID: 6443377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opiate-dependent patients receiving methadone. How physicians should manage therapy.
    Kahan M; Sutton N
    Can Fam Physician; 1996 Sep; 42():1769-78. PubMed ID: 8828879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2006 May; 82(3):211-7. PubMed ID: 16219428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methadone maintenance treatment: outcomes from the Otago methadone programme.
    Dore GM; Walker JD; Paice JR; Clarkson S
    N Z Med J; 1999 Nov; 112(1100):442-5. PubMed ID: 10678242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sexual abuse history and treatment outcomes among women undergoing methadone treatment.
    Bartholomew NG; Courtney K; Rowan-Szal GA; Simpson DD
    J Subst Abuse Treat; 2005 Oct; 29(3):231-5. PubMed ID: 16183472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies.
    Kashiwagi M; Arlettaz R; Lauper U; Zimmermann R; Hebisch G
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):140-4. PubMed ID: 15683373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.
    Grella CE; Hser YI; Huang YC
    Child Abuse Negl; 2006 Jan; 30(1):55-73. PubMed ID: 16406024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
    Fhima A; Henrion R; Lowenstein W; Charpak Y
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness comparison of Jitai tablets versus methadone in community-based drug treatment: a 1-year follow-up study.
    Hao SQ; Zhao M; Zhang RW; Zhang JC; Zhang J; Feng XS
    Addict Behav; 2013 Oct; 38(10):2596-600. PubMed ID: 23827820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of methadone treatment on registered convictions and arrests in HIV-positive and HIV-negative men and women with one or more treatment periods.
    Stenbacka M; Leifman A; Romelsjö A
    Drug Alcohol Rev; 2003 Mar; 22(1):27-34. PubMed ID: 12745356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to methadone maintenance treatment of opiate dependent patients with and without significant pain.
    Ilgen MA; Trafton JA; Humphreys K
    Drug Alcohol Depend; 2006 May; 82(3):187-93. PubMed ID: 16219429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment outcome predictors in flexible dose-duration methadone detoxification program.
    Ekhtiari H; Dezfouli A; Zamanian B; Ghodousi A; Mokri A
    Arch Iran Med; 2013 Oct; 16(10):599-601. PubMed ID: 24093142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study.
    Gossop M; Green L; Phillips G; Bradley B
    Br J Psychiatry; 1989 Mar; 154():348-53. PubMed ID: 2597836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors Associated with Relapse among Heroin Addicts: Evidence from a Two-Year Community-Based Follow-Up Study in China.
    Rong C; Jiang HF; Zhang RW; Zhang LJ; Zhang JC; Zhang J; Feng XS
    Int J Environ Res Public Health; 2016 Jan; 13(2):177. PubMed ID: 26828510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.